Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity
- 15 February 1981
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 27 (2), 191-198
- https://doi.org/10.1002/ijc.2910270211
Abstract
The plasminogen activator content of the extracts of excised prostate cancers (25 specimens) was determined with an azocasein assay and found to be on the average 1.7 times higher than that of extracts of excised prostate benign hyperplasias (29 specimens). Both groups contained the same average percentage of human urokinase type activator (∼45%) as determined by the inhibition of activity when anti‐human urokinase antibody was included in the assay system. The two types of activators were partially purified and found to have distinctly different properties. The most striking difference was the large augmentation of activity of the non‐urokinase enzyme in fibrinolysis. The implications of an enhanced fibrinolysis relative to azocaseinolysis (or other) is discussed, particularly with respect to its importance in the quantitation and characterization of activators by different investigators. Highly purified urokinase‐like activator was found to be similar to commercial urokinase preparation with respect to molecular weight, isoelectric point, inhibition by the antibody, and inhibition by placenta inhibitor.This publication has 29 references indexed in Scilit:
- Augmentation of streptokinase activator activity by fibrinogen or fibrinThrombosis Research, 1980
- No crossreaction between circulating plasminogen activator and urokinaseThrombosis Research, 1979
- Inhibition of plasminogen activators by naturally occurring inhibitors in manAmerican Journal of Physiology-Legacy Content, 1972
- Fibrinogenolysis and Fibrinolysis with Tissue Plasminogen Activator, Urokinase, Streptokinase-Activated Human Globulin, and PlasminExperimental Biology and Medicine, 1971
- Partial Purification and Properties of Urokinase Inhibitor from Human PlacentaThe Journal of Biochemistry, 1970
- Plasminogen activator in the human prostateJournal of Clinical Pathology, 1969
- Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinaseJCI Insight, 1968
- Purification of rabbit kidney cytokinase and a comparison of its properties with human urokinaseBiochemical Journal, 1968
- Partial Purification and Properties of the Plasminogen Activator from Pig Heart*Biochemistry, 1964
- Fibrinolysis and Thromboplastic Activity in Relation to Hemorrage in Transvesical ProstatectomyScandinavian Journal of Clinical and Laboratory Investigation, 1961